Skip to main content
HCSGHealthcare Services Group, Inc.Sell5.5·$23.57
HCSG · Decision

Should you buy Healthcare Services Group (HCSG)?

Updated

Healthcare Services Group trades just 2.2% below analyst consensus, delivering an unfavorable 0.4-to-1 reward-to-risk profile despite three consecutive earnings beats with large positive surprises and free cash flow conversion at 139% of net income; elevated leverage and near-exhausted price upside make adding exposure inadvisable at current levels.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
5.5/10
Price
$23.57
Entry / Take Profit (TP) / Stop Loss (SL)
/ $23.45 / $22.43

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

The company has delivered three consecutive quarterly earnings beats with large positive surprises — 72%, 96%, and 197% in the most recent three quarters — signaling a period of consistent delivery against analyst estimates after a severe miss in the oldest quarter reviewed.

Stable
Earnings
Expectation
EPS beats continue for at least 2 more consecutive quarters with positive surprises above 20%, sustaining the recent delivery track record.

CounterThe oldest quarter in the reviewed period was a severe miss at -315% surprise, demonstrating that earnings can be highly volatile; the elevated RSI of 75 suggests the market may have already priced in expectations of continued beats.

Free cash flow conversion stands at 139% of net income, indicating the business generates significantly more cash than reported earnings — a sign of conservative accounting and strong working capital dynamics.

Stable
Quality breakdown
Expectation
FCF/NI ratio remains above 100% over the next 4 quarters, confirming the conversion quality is structural rather than episodic.

CounterThe absence of an identifiable competitive moat limits pricing power, which may eventually pressure the operating margins that underpin the high cash conversion ratio.

With the stock just 2.2% below the analyst consensus target and a 0.4-to-1 reward-to-risk ratio, the current setup offers minimal potential gain against 12.9% of implied downside — a configuration that does not compensate for the risk of holding.

Stable
Price targets
Expectation
Setup improves as either the price retreats to create better asymmetry, or analysts raise consensus targets to deliver more than 15% of upside headroom.

CounterNear-term momentum remains strong — RSI at 75, volume accumulation, and the stock holding above its 200-day moving average — which could carry the price beyond current consensus targets before any meaningful pullback.

▸ Show 1 more pillar

A debt-to-equity ratio of 2.9 represents elevated leverage that constrains financial flexibility and reduces the business's ability to absorb earnings shortfalls without balance sheet stress.

Stable
Bear case
Expectation
Debt-to-equity declines below 2.0 over the next 4 quarters as earnings growth enables deleveraging.

CounterA Piotroski F-score of 7 out of 9 indicates financial statement health across multiple accounting dimensions, suggesting the leverage is being managed within the firm's capacity to service it.

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The company has delivered three consecutive quarterly earnings beats with large positive surprises — 72%, 96%, and 197% in the most recent three quarters — signaling a period of consistent delivery against analyst estimates after a severe miss in the oldest quarter reviewed.

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters.

  • P2Free cash flow conversion stands at 139% of net income, indicating the business generates significantly more cash than reported earnings — a sign of conservative accounting and strong working capital dynamics.

    Trip ifFCF/NI ratio falls below 100% for 2 consecutive reporting quarters.

  • P3With the stock just 2.2% below the analyst consensus target and a 0.4-to-1 reward-to-risk ratio, the current setup offers minimal potential gain against 12.9% of implied downside — a configuration that does not compensate for the risk of holding.

    Trip ifAnalyst consensus price target is raised such that upside to the new target exceeds 15% from the prevailing price.

  • P4A debt-to-equity ratio of 2.9 represents elevated leverage that constrains financial flexibility and reduces the business's ability to absorb earnings shortfalls without balance sheet stress.

    Trip ifDebt-to-equity ratio falls below 2.0 over 2 consecutive reporting periods.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Healthcare Services Group, Inc. (HCSG) is SELL_IF_HOLDING with medium conviction, score 5.5/10 at $23.57. The F-path SELL output reflects an overall score of 4.0 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of -0.24 is supplementary context, not the trigger.

2. What would change the verdict

The dominant failed gate is reward-to-risk (NEGATIVE). SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:6.6>=5.5.

3. What the engine sees

On the bull side: Strong earnings beat streak (3/4). On the bear side: Analyst target reached - limited upside remaining; Near 52-week high (3.0% away); Leverage penalty (D/E 2.9): -1.5. Active engine warnings: V8: Target reached (-3.6% upside), V9 Gate Failed: ASYMMETRY:-0.2=NEGATIVE.

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $23.57, with structural invalidation at $22.43. The asymmetric R:R against a reversal hypothesis is -0.15 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates HCSG — 10-dimension breakdown →

Bull case

  • Strong earnings beat streak (3/4)

Bear case

  • Analyst target reached - limited upside remaining
  • Near 52-week high (3.0% away)
  • Leverage penalty (D/E 2.9): -1.5
Home Stocks HCSG Buy or sell?